Oppenhaim Eitan sold $781K of NVMI

Oppenhaim Eitan sold 1,504 shares of NOVA LTD. (NVMI) at $519.48 ($0.78M total) on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Oppenhaim Eitan
Published May 27, 2026, 2:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 2:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NVMI
Neutral
medium confidence
Mentioned
$NVMI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVMINeutralLow
01

Why it matters

Because the sale is explicitly pre-arranged, it is generally treated as lower-information than unscheduled selling; the main trading implication is sentiment/positioning rather than a fundamental change.

02

Market read

A disclosed director sale in NVMI under 10b5-1 is more likely a routine liquidity event than a new negative catalyst.

03

What to watch

The article provides only one sale; without context on prior insider activity, total insider net selling, and whether other executives also sold, directional inference is weak.

Relevance 6/10Timing: Immediate (same-day disclosure) but likely limited follow-through.

Background

This is a SEC Form 4 insider transaction: director Oppenhaim Eitan sold 1,504 NVMI shares for ~$781.3K on 2026-05-26 under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$NVMINeutralMedium confidence
Context

NOVA Ltd. (NVMI) disclosed an insider open-market sale by director Oppenhaim Eitan of 1,504 shares at $519.48 on 2026-05-26.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and outweighed by broader fundamentals.

Evidence & confidence

Insider sales under Rule 10b5-1 are often pre-planned and may not reflect new negative information; the disclosed size is modest relative to typical liquidity, and no other company-specific catalyst is mentioned.

Market effects

Minimal—single insider sale without additional operational/regulatory updates offers little sector read-across.

None indicated; disclosure is company-specific.

None indicated beyond standard US insider reporting.

Counterpoint

Even with 10b5-1, repeated or accelerating insider sales can precede weaker sentiment; traders may still monitor for a trend across filings.

Key entities

  • NOVA Ltd.

    Company whose shares were sold by a director under a 10b5-1 plan (NVMI).

  • Oppenhaim Eitan

    Director who executed the open-market sale disclosed in the Form 4.

  • Rule 10b5-1 plan

    Pre-arranged plan that typically reduces the informational value of insider sales.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVMIMed

Nova Q3 Earnings Call Highlights

Nova (NVMI) reported strong Q3 results, with record advanced packaging sales and significant demand for its WMC platform. Logic and foundry accounted for 61% of product revenue. The company forecasted Q4 revenue of $305M-$315M and expects GAAP EPS of $2.78-$2.94. Nova ended Q3 with $1.8B in cash and repurchased $38.5M of shares. It plans to discuss future strategy at an investor day in March 2027.

$NVMIMed

Nova Ltd (NVMI) Q3 2026 Earnings Call Highlights: Record Revenue, $1 Billion Milestone

Nova Ltd (NVMI) reported record Q3 2026 revenue, reaching $1 billion. The company faces supply chain constraints and expects new competition in materials metrology. Gross margin is guided to remain flat at 59%. Operating expenses are expected to increase in Q4 2026 due to higher R&D spending. CEO Gabriel Waisman highlighted growth opportunities in memory and gate-all-around metrology, with strong demand for the Metrion tool despite longer lead times.

$NVMIHighAI 8/10

Nova (NVMI) Q3 2026 Earnings Call Transcript

Nova (NVMI) reported Q3 2026 revenue of $287.8M, up 13% QoQ and 28% YoY, driven by strong demand in memory, advanced packaging, and logic segments. The company expects to exceed $1B in annual revenue, a year ahead of plan. Q4 guidance projects revenue between $305M-$315M and EPS between $2.78-$2.94 (GAAP) and $3.03-$3.18 (non-GAAP).